Unifirst Corp: Form 10-Q for the period ended May 25, 2024
Filed with the SEC on Jul 3, 2024 and accepted by EDGAR at Jul 3, 2024, 14:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-05-25. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-02-25 to 2024-05-25 | $603.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-08-27 to 2024-05-25 | $1.79bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-02-25 to 2024-05-25 | $391.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2023-08-27 to 2024-05-25 | $1.17bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2024-02-25 to 2024-05-25 | $129.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-08-27 to 2024-05-25 | $383.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-02-25 to 2024-05-25 | $48.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-08-27 to 2024-05-25 | $129.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-02-25 to 2024-05-25 | $11.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-08-27 to 2024-05-25 | $31.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-02-25 to 2024-05-25 | $38.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-08-27 to 2024-05-25 | $100.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-02-25 to 2024-05-25 | $2.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-08-27 to 2024-05-25 | $5.38 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2024-02-25 to 2024-05-25 | 18,705,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-08-27 to 2024-05-25 | 18,738,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-08-27 to 2024-05-25 | $193.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-08-27 to 2024-05-25 | $121.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2023-08-27 to 2024-05-25 | $17.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2023-08-27 to 2024-05-25 | $16.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-05-25 | $112.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-05-25 | $884.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-05-25 | $2.65bn | us-gaap:Assets |
| Current liabilities | At period end2024-05-25 | $269.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-05-25 | $575.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-05-25 | $2.08bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-081314. Last ingested by Listed: Nov 3, 2026, 21:35 ET. Listed shows no prices and gives no investment advice.